What is the most effective method to suppress or delay my menstrual cycle for one cycle, considering I have a contraindication to estrogen due to a family history of pulmonary embolism (PE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Norethindrone (Progestin-Only Pills) for Menstrual Suppression

For one-cycle menstrual suppression with an estrogen contraindication due to family history of PE, norethindrone (progestin-only pills) taken continuously without a hormone-free interval is the most effective and safest option.

Why Progestin-Only Methods Are Appropriate

Given your family history of pulmonary embolism from estrogen-containing medication, combined hormonal contraceptives (containing estrogen) are contraindicated. Family history of estrogen-associated VTE is classified as a higher risk factor for recurrent DVT/PE, making progestin-only methods the clear choice 1.

  • Progestin-only contraceptives have substantially less thrombotic risk compared to combined oral contraceptives containing estrogen 1
  • While some recent data suggest DMPA may carry a small increased VTE risk, progestin-only pills (POPs) show minimal to no increased thrombotic risk 1
  • Women with higher risk for recurrent DVT/PE (including those with family history of estrogen-associated VTE) can use progestin-only pills with a Category 2 classification (benefits generally outweigh risks) 1

Recommended Regimen: Continuous Norethindrone

Take norethindrone 0.35 mg daily continuously (without any pill-free days) starting 5-7 days before your expected period and continuing through the event you need to avoid menstruation 2.

How It Works for Menstrual Suppression

  • Norethindrone suppresses ovulation in approximately 50% of users and alters the endometrium to prevent bleeding 2
  • Continuous dosing (without hormone-free intervals) maintains endometrial suppression and prevents withdrawal bleeding 1
  • Peak plasma concentrations occur within 1-2 hours, with a half-life of approximately 8 hours, requiring daily dosing 2

Timing and Duration

  • Start norethindrone at least 5-7 days before your expected period (based on your typical 28-day cycle from your LMP) 1
  • Continue taking one pill daily at the same time each day through the period you need to suppress menstruation 1
  • You can stop after the event, and your period should resume within 2-5 days of discontinuation 2

Alternative: Levonorgestrel IUD (If Time Permits)

If you have several weeks before needing menstrual suppression, a levonorgestrel IUD could be considered, though this is less practical for one-cycle suppression:

  • The levonorgestrel IUD significantly reduces menstrual bleeding and can cause amenorrhea, but this effect typically takes 3-6 months to develop 3
  • It provides effective menstrual suppression while avoiding exogenous estrogen exposure 1
  • This option is more suitable for long-term menstrual management rather than single-cycle suppression 3

Why Not Other Options

DMPA (Depo-Provera) - Not Ideal for Single Cycle

  • DMPA requires injection every 13 weeks and causes prolonged effects that cannot be easily reversed 1
  • Recent evidence suggests DMPA may carry increased VTE risk in patients with thrombotic risk factors 1
  • Menstrual irregularities are nearly universal initially, making it unpredictable for single-cycle suppression 1

Combined Hormonal Methods - Contraindicated

  • All combined estrogen-progestin contraceptives significantly increase VTE risk (HR 1.88-2.11 for DVT, HR 1.98 for PE) 1
  • Your family history of estrogen-associated PE makes these methods inappropriate 1
  • Even transdermal estrogen increases thrombotic risk, though possibly less than oral formulations 4

Important Considerations and Pitfalls

Breakthrough Bleeding Risk

  • Approximately 30-50% of women experience unscheduled spotting or bleeding when first starting continuous progestin-only pills 1
  • This risk decreases with continued use, but for single-cycle suppression, breakthrough bleeding remains a possibility 1
  • Starting 5-7 days before expected menses (rather than waiting until bleeding starts) improves suppression success 1

Strict Timing Requirements

  • Norethindrone must be taken at the same time each day (within a 3-hour window) to maintain effectiveness 2
  • Missing a pill or taking it >3 hours late can trigger breakthrough bleeding 1
  • Set a daily alarm to ensure consistent timing 1

Not 100% Effective for Suppression

  • While norethindrone is highly effective for contraception (0.5% perfect-use failure rate), menstrual suppression success rates are lower 2
  • Some women will experience breakthrough bleeding despite perfect adherence 1
  • Having backup menstrual products available is prudent 1

What to Expect

Side Effects

  • Menstrual irregularities (most common) 1
  • Mild headache, breast tenderness, or mood changes (less common) 2
  • Nausea (uncommon with progestin-only pills) 1

After Stopping

  • Expect withdrawal bleeding 2-5 days after discontinuing norethindrone 2
  • Your normal menstrual cycle should resume within 1-2 cycles 2
  • No long-term effects on fertility 2

Obtaining Norethindrone

  • Norethindrone requires a prescription 2
  • Inform your provider about your family history of estrogen-associated PE 1
  • Request enough pills to cover the suppression period plus 2-3 extra days as buffer 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Benefits of IUDs for Perimenopausal Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hormone therapy and risk of venous thromboembolism among postmenopausal women.

Climacteric : the journal of the International Menopause Society, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.